(Q45214600)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15636679%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

title

Phase I/II trial of bortezomib plus docetaxel in patients with advanced androgen-independent prostate cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15636679%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

main subject

phase II clinical trial

0 references

phase I clinical trial

0 references

1 reference

Nancy Price

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15636679%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Robert Dreicer

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15636679%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

publication date

1 December 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15636679%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

published in

Clinical prostate cancer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15636679%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15636679%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

141-143

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15636679%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15636679%20AND%20SRC:MED&resulttype=core&format=json

Blockade of NF-kappaB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis

7 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1540-0352%2811%2970076-2

7 January 2021

Proteasome inhibitor PS-341 down-regulates prostate-specific antigen (PSA) and induces growth arrest and apoptosis of androgen-dependent human prostate cancer LNCaP cells

1 reference

https://api.crossref.org/works/10.1016%2FS1540-0352%2811%2970076-2

7 January 2021

Phase I trial of the proteasome inhibitor bortezomib in patients with advanced solid tumors with observations in androgen-independent prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1540-0352%2811%2970076-2

7 January 2021

Human prostatic carcinoma cells produce an increase in the synthesis of interleukin-6 by human osteoblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1540-0352%2811%2970076-2

7 January 2021

Interleukin-6 is an autocrine growth factor in human prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1540-0352%2811%2970076-2

7 January 2021

10.1016/S1540-0352(11)70076-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15636679%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference